US approves first nasal spray for anaphylaxis
BMJ
.
2024 Aug 12:386:q1789.
doi: 10.1136/bmj.q1789.
Author
Elisabeth Mahase
1
Affiliation
1
The BMJ.
PMID:
39134319
DOI:
10.1136/bmj.q1789
No abstract available
Publication types
News
MeSH terms
Anaphylaxis* / drug therapy
Drug Approval*
Humans
Nasal Sprays*
United States
United States Food and Drug Administration*
Substances
Nasal Sprays